Extranodal Natural Killer/T-cell lymphoma, nasal type: ‘midline lethal granuloma.’ A case report

Head & Face Medicine

Liviu Feller³  Johan Lemmer³  Meschack Bida⁴  Razia AG Khammissa³  Monica Kotu¹  Martha M Tlholoe² 

[1] Department of Otorhinolaryngology, University of Limpopo, Medunsa Campus, South Africa;Department of Maxillofacial and Oral Surgery, University of Limpopo, Medunsa Campus, South Africa;Department of Periodontology and Oral Medicine, University of Limpopo, Medunsa Campus, South Africa;Department of Pathology, University of Limpopo, Medunsa Campus, South Africa

关键词: Extranodal NK/T cell lymphoma;    Midline lethal granuloma;   

Others  :  813789
DOI  :  10.1186/1746-160X-9-4

 received in 2012-09-13, accepted in 2013-01-11,  发布年份 2013

【 摘 要 】

Extranodal natural killer/T cell lymphoma, nasal type, is a non-Hodgkin lymphoma, most commonly affecting the nasal cavity, paranasal sinuses and nasopharynx. Clinically it is characterised by destruction of facial tissues, commencing in the midline. In most cases it arises from malignant transformation of natural killer cells (NK); sometimes from malignant transformation of cytotoxic T cells.

Extranodal NK/T cell lymphoma, nasal type, is rare, but even more rare in black persons. The purpose of this article is to report a severe case of extranodal NK/T cell lymphoma, nasal type, in an elderly black male.

【 授权许可】

   
2013 Thloloe et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Hasserjian RP, Harris NL: NK-cell lymphomas and leukemias: a spectrum of tumors with variable manifestations and immunophenotype. Am J Clin Pathol 2007, 127:860-868.
• [2]Rodrigo JP, Suarez C, Rinaldo A, Devaney KO, Carbone A, Barnes L, Heffner DK, Ferlito A: Idiopathic midline destructive disease: fact or fiction. Oral Oncol 2005, 41:340-348.
• [3]Isobe K, Uno T, Tamaru J, Kawakami H, Ueno N, Wakita H, Okada J, Itami J, Ito H: Extranodal natural killer/T-cell lymphoma, nasal type: the significance of radiotherapeutic parameters. Cancer 2006, 106:609-615.
• [4]Al-Hakeem DA, Fedele S, Carlos R, Porter S: Extranodal NK/T-cell lymphoma, nasal type. Oral Oncol 2007, 43:4-14.
• [5]Neville B, Damm D, Allen C, Bouquot J, Neville B: Hematologic Disorders. In Oral and Maxillofacial Pathology. 3rd edition. Edited by Neville B, Damm D, Allen C, Bouquot J, Neville B. Missouri: Saunders Elsevier; 2009.
• [6]Liang R: Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type. Br J Haematol 2009, 147:13-21.
• [7]Chiang AK, Tao Q, Srivastava G, Ho FC: Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin’s disease. Int J Cancer 1996, 68:285-290.
• [8]Gill H, Liang RH, Tse E: Extranodal natural-killer/t-cell lymphoma, nasal type. Adv hematol 2010, 2010:627401.
• [9]Kim TM, Park YH, Lee SY, Kim JH, Kim DW, Im SA, Kim TY, Kim CW, Heo DS, Bang YJ, et al.: Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal type. Blood 2005, 106:3785-3790.
• [10]Yamaguchi M, Oqawa S, Nomoto Y, Oka K, Taniguchi M, Nakase K, Kobayashi T, Shiku H: Treatment outcome of nasal NK-cell lymphoma: a report of 12consecutively-diagnosed cases and a review of theliterature. J Clin Exp Hematopathol 2001, 41:93-99.
• [11]Lee J, Suh C, Park YH, Ko YH, Bang SM, Lee JH, Lee DH, Huh J, Oh SY, Kwon HC, et al.: Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol 2006, 24:612-618.
• [12]Ai WZ, Chang ET, Fish K, Fu K, Weisenburger DD, Keegan TH: Racial patterns of extranodal natural killer/T-cell lymphoma, nasal type, in California: a population-based study. Br J Haematol 2012, 156:626-632.
• [13]Lee J, Park YH, Kim WS, Lee SS, Ryoo BY, Yang SH, Park KW, Kang JH, Park JO, Lee SH, et al.: Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy. Eur J Cancer 2005, 41:1402-1408.
• [14]Lee J, Kim WS, Park YH, Park SH, Park KW, Kang JH, Lee SS, Lee SI, Lee SH, Kim K, et al.: Nasal-type NK/T cell lymphoma: clinical features and treatment outcome. Br J Cancer 2005, 92:1226-1230.
• [15]Cabrera ME, Eizuru Y, Itoh T, Koriyama C, Tashiro Y, Ding S, Rey S, Akiba S, Corvalan A: Nasal natural killer/T-cell lymphoma and its association with type “i”/XhoI loss strain Epstein-Barr virus in Chile. J Clin Pathol 2007, 60:656-660.
• [16]Ohshima K, Suzumiya J, Shimazaki K, Kato A, Tanaka T, Kanda M, Kikuchi M: Nasal T/NK cell lymphomas commonly express perforin and Fas ligand: important mediators of tissue damage. Histopathology 1997, 31:444-450.
• [17]Ooi GC, Chim CS, Liang R, Tsang KW, Kwong YL: Nasal T-cell/natural killer cell lymphoma: CT and MR imaging features of a new clinicopathologic entity. Am J Roentgenol 2000, 174:1141-1145.
• [18]Meer S, Van Heerden WFP: Clinicopathologic Conference: Case 2. Head Neck Pathol 2008, 2:279-282.
• [19]Harabuchi Y, Imai S, Wakashima J, Hirao M, Kataura A, Osato T, Kon S: Nasal T-cell lymphoma causally associated with Epstein-Barr virus: clinicopathologic, phenotypic, and genotypic studies. Cancer 1996, 77:2137-2149.